The global pharmaceutical industry experienced a 14% decline in patent filings in Q3 2024 compared with the previous quarter. The total number of grants dropped by 21%, resulting in overall patent publications decreasing by 14.2%, according to GlobalData’s Patent Analytics. GlobalData’s databook Pharma: Patents Trends Q3 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Smarter leaders trust GlobalData
Notably, the number of patent applications in the pharmaceutical industry was 62,965 in Q3 2024, versus 73,396 in the prior quarter. Filings were down 11% year-on-year and decrease 14% quarter-on-quarter. This compares to an 11% year-on-year decrease in patent grants and 14% decline in quarter-on-quarter.
The top five companies accounted for 3% of patenting activity
Analysis of patenting activity by companies shows that the largest number of patents filed over the last quarter was by Roche with 538, followed by Zhejiang University with 359 and Regeneron Pharmaceuticals with 354.
Patenting activity was driven by China with a 33% share of total patent filings
The largest share of patent filings in the pharmaceutical industry in Q3 2024 was in China with 33%, followed by the US (14%) and Japan (6%). The share represented by China was 10% lower than the 43% share it accounted for in Q2 2024.
For further understanding of GlobalData's Pharma: Patents Trends Q3 2024, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
